Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could weekly IV line changes cut ICU workload without raising infection risk?

NCT ID NCT07183592

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares changing IV tubing every 7 days versus every 4 days in ICU patients with central venous catheters. The goal is to see if the longer interval increases infection rates. About 2,830 adults will take part. If 7-day changes are safe, it could save nursing time and reduce medical waste.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Infusion set replacement procedure
What this could lead to
If successful, this could show that changing IV tubing every 7 days is as safe as every 4 days, potentially reducing nurse workload and hospital costs without raising infection risk.
What could go wrong
This is a large but early-stage trial. The 7-day schedule might still lead to more infections, and results may not apply to all ICU patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 2,830 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria * Adult patient * Any ICU patient with a central venous catheter (inserted by venipuncture) in place for less than 72 hours and with an expected dwell time of at least 7 days * Patient affiliated with or covered by a social security system * Patient who has given verbal consent or written consent from a third party or in the event that the patient is unable to give consent. Exclusion Criteria * Patient with a documented bloodstream infection at the time of inclusion * Patient whose central venous catheter has been in place for more than 72 hours * Patient with suspected catheter-related infection * Patient whose study catheter was inserted using a guidewire exchange * Patient previously enrolled in the study during the same ICU stay * Patient whose condition, according to the clinician, does not allow safe placement of a central venous catheter, such as: * Allergy to catheter material * Confirmed deep vein thrombosis at the time of insertion * Inflammatory skin disorder at the insertion site * Patient admitted for extensive burns * Inadequate understanding of the French language * Pregnant, breastfeeding, or postpartum woman * Person deprived of liberty by judicial or administrative decision * Person receiving involuntary psychiatric care * Person under legal guardianship or other legal protection measure

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Catheter-associated bloodstream infections (clabsi) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    27 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AP-HP - Henri Mondor Hospital

    NOT_YET_RECRUITING

    Créteil, 94000, France

  • AP-HP - Saint Louis

    NOT_YET_RECRUITING

    Paris, 75475, France

  • AP-HP - Tenon Hospital

    NOT_YET_RECRUITING

    Paris, 75020, France

  • Albi Hospital

    NOT_YET_RECRUITING

    Albi, 81000, France

  • Angers University Hospital

    RECRUITING

    Angers, 49933, France

  • Belfort Hospital

    NOT_YET_RECRUITING

    Belfort, 90015, France

  • Bourges Hospital

    NOT_YET_RECRUITING

    Bourges, 18000, France

  • CH Carcassonne

    NOT_YET_RECRUITING

    Carcassonne, 11000, France

  • CH Le Mans

    NOT_YET_RECRUITING

    Le Mans, 72000, France

  • CH Saint-Nazaire

    NOT_YET_RECRUITING

    Saint-Nazaire, 44606, France

  • CHU Rennes - service MIR

    NOT_YET_RECRUITING

    Rennes, 35033, France

  • CHU Rennes - service Réa chir

    NOT_YET_RECRUITING

    Rennes, 35033, France

  • CHU Tours

    NOT_YET_RECRUITING

    Tours, 37000, France

  • Caen University Hospital

    NOT_YET_RECRUITING

    Caen, 14033, France

  • Chartres Hospital

    NOT_YET_RECRUITING

    Chartres, France

  • Cholet Hospital

    NOT_YET_RECRUITING

    Cholet, 49300, France

  • Colombes Hospital

    NOT_YET_RECRUITING

    Colombes, 92700, France

  • Corbeil-Essonnes Hospital

    NOT_YET_RECRUITING

    Corbeil-Essonnes, 91106, France

  • Dijon University Hospital

    NOT_YET_RECRUITING

    Dijon, 21079, France

  • Garches Hospital

    NOT_YET_RECRUITING

    Garches, France

  • La Réunion University Hospital

    NOT_YET_RECRUITING

    Saint-Pierre, La Réunion, BP350 97448, France

  • Le Puy en Velay Hospital

    NOT_YET_RECRUITING

    Le Puy-en-Velay, 43000, France

  • Macon Hospital

    NOT_YET_RECRUITING

    Mâcon, 71000, France

  • Nantes University Hospital

    NOT_YET_RECRUITING

    Nantes, 44093, France

  • Orleans University Hospital

    NOT_YET_RECRUITING

    Orléans, 45067, France

  • Pontoise Hospital

    NOT_YET_RECRUITING

    Pontoise, 95300, France

  • Strasbourg University Hospital

    NOT_YET_RECRUITING

    Strasbourg, 67091, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.